Rafael Holdings, Inc. (RFL)
$1.43-4.03%Close
SELLCRISIS · day 26
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $73M
- Beta
- 0.35
- P/E (TTM)
- -2.10
- Short % float
- 3.13%
- Days to cover
- 2.3
- SI change
- -0.3%
- 1W
- -3.38%
- 1M
- -33.18%
- vs SPY 1W
- -3.24%
- vs SPY 1M
- -35.68%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 9
- GROWTH
- 19
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-23.4%
REV YoY-
ROE-39.0%
EPS YoY-
ROA-35.4%
GROSS84
OP-3717
NET-3322
[VALUATION]
P/E TTM-2.10
P/E FWD-
SECTOR PE36.74
INDUSTRY PE22.14
P/B0.97
P/FCF-
EV/EBITDA-1.40
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E0.81
ALTMAN Z-
CURR RATIO3.16
ND/EBITDA-
BETA0.35
Company news
FAQ
- What is LOPJLB’s current signal on RFL?
- LOPJLB’s latest quantitative signal on Rafael Holdings, Inc. (RFL) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is RFL in?
- Rafael Holdings, Inc. (RFL) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Rafael Holdings, Inc. (RFL) do?
- Rafael Holdings, Inc. holds strategic investments in both early-stage and clinical pharmaceutical companies, alongside a portfolio of commercial real estate assets situated in the United States and Israel. The company's business activities are structured into two primary divisions: Pharmaceuticals and Real Estate. Its Real Estate segment manages and leases a commercial office complex, which fea…